CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 1,200 shares, a drop of 70.7% from the June 15th total of 4,100 shares. Based on an average daily trading volume, of 349,700 shares, the days-to-cover ratio is currently 0.0 days.

CNBX Pharmaceuticals Stock Performance

CNBX remained flat at $0.01 during trading hours on Thursday. The company had a trading volume of 1,028 shares, compared to its average volume of 251,235. CNBX Pharmaceuticals has a 52 week low of $0.01 and a 52 week high of $0.05. The firm’s 50-day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.